wellrank.ai
PCAB logo

PCAB

First cited by AI Jun 12, 2026
pcabroker.com

Surfaced organically in AI answers about compounded glp-1s. Not yet profiled.

AI Visibility

Visibility trend

Ozempic, daily share of AI answers mentioning PCAB, through Jun 13, 2026.

8.3%

Avg position when mentioned: 2.0

By engine

Where PCAB is strong, and where it is invisible.

  • Perplexity
    33.3%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 2 positive mentions
  • 0 neutral
  • 0 mixed or cautious

Recent AI answers mentioning PCAB

PerplexityJun 13, 2026, 11:12 UTC
Is there a cheaper generic or compounded version of Ozempic and where do I get it safely?

There is no FDA-approved generic Ozempic in the U.S. right now, but there are safer lower-cost alternatives such as manufacturer savings programs, authorized generics for related drugs, and—only in limited circumstances—compounded semaglutide from a licensed compounding pharmacy.[5][2] The key safety point is that compounded semaglutide is not FDA-approved and the FDA says compounded drugs are not reviewed for safety, effectiveness, or quality before marketing.[8] The FDA also warns about counterfeit Ozempic and unapproved GLP-1 products sold online, which may contain the wrong amount of drug or harmful ingredients.[8] Where to get it safely Start with your prescriber or endocrinologist, who can confirm whether you actually need Ozempic, a related FDA-approved option, or a compounded option.[1][8] If a compounded version is medically appropriate, use a licensed compounding pharmacy; experts specifically recommend checking for PCAB accreditation and avoiding sellers that do not require a prescription.[2][8] Be cautious with telehealth sites advertising “generic Ozempic”; GoodRx notes compounded semaglutide is often marketed that way, but it is not a true generic.[5] Cheaper options to ask about Ozempic savings programs or cash-pay discounts, if you qualify.[2] Rybelsus (oral semaglutide) for type 2 diabetes, which uses the same active ingredient as Ozempic and may have manufacturer savings options.[3] Wegovy cash-pay or savings programs for weight loss if that is your indication.[2] Generic liraglutide (the active ingredient in Victoza/Saxenda) where available, which may be cheaper than branded GLP-1s.[2][3] If you tell me whether you need it for type 2 diabetes or weight loss, and what country you’re in, I can point you to the safest lower-cost options to ask your doctor about.

Mentioned in position 2 of 2

Read full answer with sources →
PerplexityJun 12, 2026, 10:28 UTC
How can I tell if an online compounded semaglutide pharmacy is FDA compliant?

You generally cannot tell that an online compounded semaglutide pharmacy is “FDA compliant” just because it says so—because compounded semaglutide is not FDA-approved. What you can verify is whether the pharmacy is operating under the FDA’s compounding rules and whether the website is a legitimate, licensed U.S. pharmacy.[8][5] What to check: Identify the pharmacy type. Legitimate compounding usually comes from a 503A state-licensed pharmacy or a 503B FDA-registered outsourcing facility; 503B facilities are FDA-registered and inspected, while 503A pharmacies are regulated primarily by state boards of pharmacy.[1][2][3] Verify the pharmacy license. The pharmacy should be licensed in the state where it dispenses and in good standing, with no expired, revoked, or disciplined license status.[2][8] Check whether it’s an actual online pharmacy. Use the NABP Safe Site Search Tool to confirm the website is recognized as legitimate and meets safety standards.[2][3] Look for a real physical U.S. address and pharmacist access. A compliant pharmacy should list a physical U.S. location and let you speak with a licensed pharmacist.[2] Check accreditation. PCAB accreditation or NABP accreditation is a strong positive sign, but it is voluntary and not the same as FDA approval.[1][2][7] Confirm the semaglutide source and labeling. FDA has warned about fraudulent compounded GLP-1 products with false labels; the product should come from a licensed pharmacy and be prescribed by a licensed clinician.[8] Be wary of “too good to be true” claims. A pharmacy should not imply compounded semaglutide is FDA-approved, and it should not be routinely compounding essentially copied versions of approved products unless the FDA’s compounding rules allow it in that specific situation.[6][8] A practical consumer checklist: Good sign: state pharmacy license is current and verifiable[2][8] Good sign: 503B registration or clear 503A compounding status[1][3] Good sign: NABP/PCAB accreditation[1][2][7] Good sign: pharmacist contact is easy to find[2] Red flag: no physical address, no pharmacist, or only a sales page[2][8] Red flag: claims the compounded product is “FDA approved”[5][8] Red flag: vague sourcing, misspelled labels, or suspicious packaging[8] If you want, I can turn this into a 5-minute verification checklist you can use on any semaglutide website.

Mentioned in position 2 of 2

Read full answer with sources →

Public AI visibility history

Daily rank of PCAB on our buyer intent questions, per category. A dash means the engines did not cite PCAB at all that day. This record is permanent.

CategoryJun 11Jun 12Jun 13
Ozempic#39
Compounded GLP-1s#91

TL;DR

PCAB (pcabroker.com) is a pharmacy accreditation body that certifies compounding pharmacies in the United States, offering a quality credential that helps patients and prescribers identify reputable compounders. It has surfaced organically in AI answers tied to the compounded GLP-1 conversation, currently ranking 15th for Ozempic-related queries with 8% visibility in the WellRank index, and both AI mentions in the corpus carry a positive tone.

Company Overview

PCAB, the Pharmacy Compounding Accreditation Board, is a nonprofit accreditation organization whose mission is to set and verify quality standards for compounding pharmacies across the United States. Its business model centers on evaluating and accrediting compounding pharmacies against rigorous standards, giving patients and clinicians a vetted signal of pharmacy quality. Founding details and headquarters location are not publicly prominent in widely available sources.

Product Features

  • Accreditation credential for compounding pharmacies that meet defined quality and safety standards
  • A searchable directory allowing patients and prescribers to locate PCAB-accredited compounders
  • Standards development covering sterile and non-sterile compounding practices
  • Education and compliance resources for pharmacy applicants seeking or maintaining accreditation
  • A recognized quality signal cited in discussions of compounded medications including compounded semaglutide

Target Market

PCAB primarily serves compounding pharmacies seeking a credible third-party quality credential, and secondarily serves healthcare providers and patients who use that credential to make informed choices about compounded medications. It is most relevant in the United States market, particularly in contexts where patients are seeking alternatives to commercially manufactured drugs, such as compounded GLP-1 agonists for weight management.

Buyer Personas

  • An independent compounding pharmacy owner who wants a recognized accreditation to differentiate their practice and signal quality to prescribers and patients.
  • A prescribing clinician evaluating which compounding pharmacies to recommend for patients needing compounded semaglutide or other specialty compounds.
  • A cost-conscious patient researching compounded GLP-1 options who uses the PCAB credential as a safety filter when reviewing pharmacy options highlighted by resources like GoodRx's guide to compounded semaglutide.
  • A health plan or pharmacy benefit manager looking for accreditation benchmarks to guide network inclusion decisions for compounding pharmacies.

Funding & Performance

PCAB operates as a nonprofit accreditation body; detailed financial figures, funding history, and organizational scale are not publicly disclosed.

Recent Developments

PCAB has gained increased relevance as regulatory scrutiny of compounded GLP-1 drugs has intensified, with the FDA raising concerns about unapproved compounded GLP-1 drugs used for weight loss and clinicians and patients turning to accreditation credentials as a quality signal. Discussions in clinical and consumer media about the differences between compounded and branded GLP-1s have elevated the profile of bodies like PCAB. No specific product launches or strategic pivots are widely reported at this time.

Competitive Landscape

In the AI answer ecosystem, PCAB is most frequently co-mentioned alongside NABP (the National Association of Boards of Pharmacy) and GoodRx, per WellRank co-mention data. NABP is its closest structural peer as another pharmacy-sector accreditation and standards body. GoodRx represents the consumer information layer that often directs patients toward accredited pharmacies. In the broader compounded GLP-1 conversation, PCAB's credential competes for mindshare with state board oversight, FDA registration status, and guidance from manufacturers like Novo Nordisk that emphasize FDA-approved products over compounded alternatives.

PCAB vs the brands AI recommends alongside it

The real competitive set in Ozempic: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
PCAB logo
PCABThis brand
#39
8.3%
GoodRx logo
GoodRx

1 shared answers

#10
16.7%

Email me when overtakes PCAB

One email the day the ranks flip. Nothing else.

User Sentiment

The WellRank corpus shows both AI mentions of PCAB carry a positive tone, with zero neutral or cautious mentions, suggesting AI engines reference PCAB as a trustworthy quality signal rather than a source of controversy. Consumer and clinical sources that discuss compounding pharmacy risks and standards tend to treat accreditation bodies like PCAB favorably as part of the patient safety infrastructure, which is consistent with this positive framing.

Pricing

Accreditation fees for pharmacies are not publicly listed on widely available sources; pricing for the accreditation process is not published in a standardized way and likely varies by pharmacy size and scope.

Sources cited around PCAB

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track PCAB weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at PCAB? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.

PCAB: AI visibility report | WellRank